Variation in Basal Serum Cortisol Levels During Treatment of Oral Lichen Planus With 0.5% Triamcinolone Acetonide Mouthrinses: A Prospective Observational Study
OBJECTIVE: To evaluate changes in basal serum cortisol levels in patients with atrophic-erosive oral lichen planus (OLP) and oral lichenoid lesion (OLL) treated with 0.5% triamcinolone acetonide mouthrinses and to assess the occurrence of clinical manifestations associated with adrenal dysfunction. METHODS: A prospective observational study was conducted in 68 patients with clinically and histopathologically confirmed atrophic-erosive OLP or OLL. Participants received 0.5% triamcinolone acetonide mouthrinses following a tapering regimen over 3 months. Basal serum cortisol levels were measured at baseline, after 30 days, and after 90 days of treatment. Clinical and demographic variables and treatment-related adverse effects were analyzed. RESULTS: Mean basal serum cortisol levels decreased from 17.05 ± 4.38 μg/dL at baseline to 8.79 ± 7.34 μg/dL after 1 month of treatment. Following dose tapering, serum cortisol levels (SCL) partially recovered to 11.94 ± 6.44 μg/dL at 3 months. No clinical manifestations of adrenal insufficiency were observed. Baseline SCL were significantly associated with serum cortisol concentrations after 1 month (r = 0.34; p < 0.05). Older patients exhibited smaller hormonal fluctuations during treatment. CONCLUSIONS: Triamcinolone acetonide induced a transient reduction in SCL without clinically relevant adrenal dysfunction, suggesting a limited systemic impact when administered a tapering regimen.
Authors
- Pilar Gándara Vila (ORCID: https://orcid.org/0000-0003-2259-7971)
- Andrés Blanco Carrión (ORCID: https://orcid.org/0000-0002-7405-1834)
- Xabier Marichalar‐Mendía (ORCID: https://orcid.org/0000-0001-5948-9443)
- Alejandro I. Lorenzo‐Pouso (ORCID: https://orcid.org/0000-0002-9180-4703)
- E Blanco-Aguilera
- E. Otero Rey (ORCID: https://orcid.org/0000-0002-9714-5518)
- Valeria Sanmartín-Barragáns
- Javier Rodríguez (ORCID: https://orcid.org/0000-0002-5631-2981)
- Antonio Blanco‐Aguilera (ORCID: https://orcid.org/0009-0009-5269-7501)
Institutions
- Andalusian Health Service (ES)
- University of the Basque Country (ES)
- Universidade de Santiago de Compostela (ES)
- Complejo Hospitalario Universitario de Santiago (ES)
- Instituto de Investigación Sanitaria de Santiago (ES)
Publication Details
- Journal
- Oral Diseases
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1111/odi.70568
- Primary Topic
- Oral Health Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00